We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Faster, Less Expensive DNA Sequencing Method Developed

By LabMedica International staff writers
Posted on 28 Dec 2009
Biomedical engineers have devised a method for making future genome sequencing faster and less expensive by considerably reducing the amount of DNA required, thus eliminating the expensive, time-consuming, and error-laden step of DNA amplification. More...


In a study published in the December 20, 2009, online edition of the journal Nature Nanotechnology, a team led by Boston University (BU; MA, USA) biomedical engineering associate professor Dr. Amit Meller detailed ground-breaking work in detecting DNA molecules as they pass through silicon nanopores. The method utilizes electrical fields to feed long strands of DNA through four-nanometer-wide pores, much like threading a needle. The technique uses sensitive electrical current measurements to detect single DNA molecules as they pass through the nanopores.

"The current study shows that we can detect a much smaller amount of DNA sample than previously reported,” said Dr. Meller. "When people start to implement genome sequencing or genome profiling using nanopores, they could use our nanopore capture approach to greatly reduce the number of copies used in those measurements.”

Currently, genome sequencing utilizes DNA amplification to make billions of molecular copies in order to generate a sample large enough to be studied. In addition to the time and cost DNA amplification entails, some of the molecules--similar to photocopies of photocopies--come out less than perfect. Dr. Meller and his colleagues at BU, New York University (New York, NY, USA) and Bar-Ilan University (Ramat-Gan, Israel) have harnessed electrical fields surrounding the mouths of the nanopores to attract long, negatively charged strands of DNA and slide them through the nanopore where the DNA sequence can be detected. Since the DNA is drawn to the nanopores from a distance, far fewer copies of the molecule are needed.

Before creating this new method, the researchers had to develop an understanding of electrophysics at the nanoscale, where the rules that govern the larger world do not necessarily apply. They made a counterintuitive finding: the longer the DNA strand, the more quickly it found the pore opening.

"That's really surprising,” Dr. Meller noted. "You'd expect that if you have a longer ‘spaghetti,' then finding the end would be much harder. At the same time this discovery means that the nanopore system is optimized for the detection of long DNA strands--tens of thousands basepairs, or even more. This could dramatically speed future genomic sequencing by allowing analysis of a long DNA strand in one swipe, rather than having to assemble results from many short snippets. DNA amplification technologies limit DNA molecule length to under a thousand base pairs. Because our method avoids amplification, it not only reduces the cost, time, and error rate of DNA replication techniques, but also enables the analysis of very long strands of DNA, much longer than current limitations.”

Utilizing this knowledge, Dr. Meller and his coworkers set out to optimize the effect. They used salt gradients to alter the electrical field around the pores, which increased the rate at which DNA molecules were captured and shortened the lag time between molecules, thus reducing the quantity of DNA needed for precise measurements. Instead of floating around until they happened upon a nanopore, DNA strands were channeled into the openings.

By increasing capture rates by a few orders of magnitude, and reducing the volume of the sample chamber, the researchers reduced the number of DNA molecules required by a factor of 10,000--from approximately 1 billion sample molecules to 100,000.


Related Links:
Boston University
New York University
Bar-Ilan University


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.